WST West Pharmaceutical Services PE ratio, current and historical analysis
The current P/E ratio for West Pharmaceutical Services stock as of Apr 24, 2025 is 31.2. This is calculated based on the TTM EPS of $6.75 and the stock price of $210.59 per share. The PE ratio has decreased by 34% from its last 4 quarters average of 47.6.
WST PE ratio history
The average historical PE ratio of West Pharmaceutical Services for the last ten years is 45.84. The current price-to-earnings ratio of 31.2 is 32% less than the historical average. Analyzing the last ten years, WST's PE ratio reached its highest point in the Sep 2020 quarter at 64.99, when the price was $274.9 and the EPS was $4.23. The lowest point was recorded in the Sep 2022 quarter, when it reached 29.19 with a price of $246.08 and an EPS of $8.43.
West Pharmaceutical Services PE ratio by year
Maximum annual increase: 52.25% in 2015
Maximum annual decrease: -43.33% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 48.53 | 9.97% | $327.56 | $6.75 |
| 2023 | 44.13 | 47.59% | $352.12 | $7.98 |
| 2022 | 29.9 | -43.33% | $235.35 | $7.87 |
| 2021 | 52.76 | -12.85% | $469.01 | $8.89 |
| 2020 | 60.54 | 31.69% | $283.31 | $4.68 |
| 2019 | 45.97 | 31.31% | $150.33 | $3.27 |
| 2018 | 35.01 | -27.62% | $98.03 | $2.8 |
| 2017 | 48.37 | 11.76% | $98.67 | $2.04 |
| 2016 | 43.28 | -4.42% | $84.83 | $1.96 |
| 2015 | 45.28 | 52.25% | $60.22 | $1.33 |
| 2014 | 29.74 | -2.4% | $53.24 | $1.79 |
| 2013 | 30.47 | 32.48% | $49.06 | $1.61 |
| 2012 | 23 | 35.77% | $27.38 | $1.19 |
| 2011 | 16.94 | -19.41% | $18.98 | $1.12 |
| 2010 | 21.02 | 19.03% | $20.6 | $0.98 |
West Pharmaceutical Services PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 48.53 | 10.1% | $327.56 | $6.75 |
| Sep 2024 | 44.08 | -4.86% | $300.16 | $6.81 |
| Jun 2024 | 46.33 | -10.2% | $329.39 | $7.11 |
| Mar 2024 | 51.59 | 16.9% | $395.71 | $7.67 |
| Dec 2023 | 44.13 | -11.67% | $352.12 | $7.98 |
| Sep 2023 | 49.96 | -9.08% | $375.21 | $7.51 |
| Jun 2023 | 54.95 | 17.51% | $382.47 | $6.96 |
| Mar 2023 | 46.76 | 56.39% | $346.47 | $7.41 |
| Dec 2022 | 29.9 | 2.43% | $235.35 | $7.87 |
| Sep 2022 | 29.19 | -11.38% | $246.08 | $8.43 |
| Jun 2022 | 32.94 | -26.37% | $302.37 | $9.18 |
| Mar 2022 | 44.74 | -15.2% | $410.71 | $9.18 |
| Dec 2021 | 52.76 | 2.79% | $469.01 | $8.89 |
| Sep 2021 | 51.33 | 0.2% | $424.54 | $8.27 |
| Jun 2021 | 51.23 | 4% | $359.1 | $7.01 |
WST average PE ratio chart
The current PE ratio of WST is under its 3, 5 and 10-year averages.
WST PE vs peers
WST's PE ratio is less than its peer stocks SYK and BDX, but it is above JNJ's and MDT's. West Pharmaceutical Services's current PE ratio of 31.2 is less than the average of its peers, which is 42.77.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 17.1 | $372.77B |
| MDT Medtronic plc | 25.47 | $108.12B |
| WST West Pharmaceutical Services Inc | 31.2 | $15.23B |
| BDX Becton Dickinson & Co | 34.3 | $58.7B |
| SYK Stryker Corp | 45.94 | $137.77B |
| TFX Teleflex Inc | 91.05 | $6.29B |
| ICUI Icu Medical Inc | N/A | $3.36B |
| BAX Baxter International Inc | N/A | $15.56B |
| PLL Piedmont Lithium Inc | N/A | $195.52M |
Frequently asked questions
What is West Pharmaceutical Services's PE ratio?
As of Apr 24, 2025, WST stock has a price to earnings ratio of 31.2.
What is the 3-year average PE ratio for West Pharmaceutical Services (WST)?
Over the last 3 years, the average PE ratio for WST stock is 43.49.
What is the 5-year average PE ratio for West Pharmaceutical Services (WST)?
Over the last 5 years, the average PE ratio for WST stock is 47.99.
What is the highest PE ratio for WST?
Over the last ten years, the quarterly PE ratio reached its highest level at 64.99 in the Sep 2020 quarter.
How does the current PE ratio for WST compare to its historical average?
The current PE ratio of WST is 32% lower than the 10-year historical average.
How is WST's PE ratio calculated (West Pharmaceutical Services PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Apr 24, 2025), West Pharmaceutical Services's share price is $210.59. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $6.75. Therefore, West Pharmaceutical Services's price to earnings ratio for today is 31.2. PE RATIO(31.2) = STOCK PRICE($210.59) / TTM EPS($6.75)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.